| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |